Reply to the letter by Takeshi Yamada et al. concerning "Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?"

J Gastroenterol. 2016 May;51(5):508. doi: 10.1007/s00535-016-1185-1. Epub 2016 Feb 20.

¹ Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, FuCheng Road 52, HaiDian District, 100142, Beijing, China.
² Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, FuCheng Road 52, HaiDian District, 100142, Beijing, China. lin100@medmail.com.cn.

No abstract available

Publication types